Sign in

Journal of Cellular & Molecular Anesthesia

e-ISSN 2476-5120
p-ISSN 2538-2462
Authors GuideSubmit manuscript
Cover image of the article: Can COVID-19 Be a risk factor for tuberculosis? COVID-19 and tuberculosis

Image Credit:J Cell Mol Anesth

Outline

https://doi.org/10.22037/jcma.v6i1.32694

Can COVID-19 Be a risk factor for tuberculosis? COVID-19 and tuberculosis

Authors

Benyamin Parseh1,*, ehsan allah kaltehehsan allah kalteh ORCID2, Mahnaz Sheikhi3, Mousa Ghelichi-GhojoghMousa Ghelichi-Ghojogh ORCID4
1PhD Applied Cell sciences, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran
2MSc of Epidemiology, Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran
3General Practitioner, Golestan University of Medical Sciences, Gorgan, Iran
4PhD Student in Epidemiology, Student Research Commitee, Shiraz University of Medical Sciences, Shiraz, Iran.
*Corresponding Author: PhD Applied Cell sciences, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran Email: benyamin_paresh@yahoo.com
Journal of Cellular & Molecular Anesthesia:Vol. 6, issue 1; e149662
Published online:Dec 04, 2020
Article type:Letter to the Editor
How to Cite:Parseh B, kalteh EA, Sheikhi M, Ghelichi-Ghojogh M. Can COVID-19 Be a risk factor for tuberculosis? COVID-19 and tuberculosis. J Cell Mol Anesth. 2021;6(1):e149662. doi: https://doi.org/10.22037/jcma.v6i1.32694

Abstract

?Most COVID-19 severe cases are presented with uncontrolled elevated level of proinflammatory cytokines such as IL-6, IL-1?, IL-2?? IL-8, IL-17, G- CSF, GM- CSF, IP10, MCP1, CCL3, and TNF which is called cytokine storm. Previous studies showed that proinflammatory cytokine overexpression such as TNF and IL-6 exacerbates TB. In COVID-19 patients, we are facing immune system imbalance due to cytokine storm. Thus, COVID-19 may be a predisposing factor to turn latent TB to active TB.

Highlights

KeywordsCOVID-19CoronavirusRisk factorTuberculosisCytokines

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Oct
2020
Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection

Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection

Rahim Soleimani Gelodar,
Sepideh Nasimzadeh,
Amin Dehghan Banadkouki,
milad zandi
PDF

Soleimani Gelodar R, Nasimzadeh S, Dehghan Banadkouki A, zandi M. Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection. J Cell Mol Anesth. 2020;5(4):e149656. doi: https://doi.org/10.22037/jcma.v5i4.32344

18
Nov
2021
High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity

High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity

Didem Ozgür,
Murat Karamese,
Alpay Medetalibeyoglu,
Onur Alkan,
Naci Senkal,
Emin Ediz Tutuncu
PDF

Ozgür D, Karamese M, Medetalibeyoglu A, Alkan O, Senkal N, et al. High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity. Jundishapur J Microbiol. 2021;14(10):e119060. doi: https://doi.org/10.5812/jjm.119060

5
Jul
2021
Overview of SARS-CoV-2 Infection and Its Potential Reactions

Overview of SARS-CoV-2 Infection and Its Potential Reactions

Esmaeil Mortaz,
Neda K. Dezfuli
PDF

Mortaz E, K. Dezfuli N. Overview of SARS-CoV-2 Infection and Its Potential Reactions. J Adv Immunopharmacol. 2021;1(2):e115161. doi: https://doi.org/10.5812/tms.115161

1
Aug
2020
Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report

Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report

Alfonso Papa,
Maria Teresa Di Dato,
Pietro Buonavolonta,
Elisabetta Saracco,
Anna Maria Salzano,
Beniamino Casale
PDF

Papa A, Di Dato MT, Buonavolonta P, Saracco E, Salzano AM, et al. Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report. Anesth Pain Med. 2020;10(4):e104151. doi: https://doi.org/10.5812/aapm.104151

23
Jul
2020
Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm

Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm

Omid Moradi,
Seyed pouzhia Shojaei,
Mehran Kouchek,
MirMohammad Miri,
Sara Salarian,
Mohammad Sistanizad
PDF

Moradi O, Shojaei SP, Kouchek M, Miri M, Salarian S, et al. Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm. J Cell Mol Anesth. 2020;5(3):e150187. doi: https://doi.org/10.22037/jcma.v5i3.30630

More by these authors

Benyamin ParsehPubMedScholar
ehsan allah kaltehPubMedScholar
Mahnaz SheikhiPubMedScholar
Mousa Ghelichi-GhojoghPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF455.58 KB
Share
Cited by
Metrics
Comments
Number of Comments:0
Indexed in
logoScopus